This poster, presented at ASH 2020, highlights findings from responses entered in the CCO interactive tool on managing AEs associated with BTK inhibitors. Analysis of clinical practice trends suggest that management of these AEs by HCPs often diverges from evidence-based expert recommendations.
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.